Prevention, Diagnosis, and Treatment of Hepatocellular Carcinoma

This JAMA Clinical Guidelines Synopsis summarizes the 2023 American Association for the Study of Liver Diseases practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma.

Authors

Institutions

Publication Details

Journal
JAMA
Published
2024-08-29
DOI
https://doi.org/10.1001/jama.2024.14101
Citations
18
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
6.65
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prevention, Diagnosis, and Treatment of Hepatocellular Carcinoma

Anjana Pillai, Sarah Park, A. Davis
18 citations
JAMA
Hepatocellular Carcinoma Treatment and Prognosis
6.65
article

Prevention, Diagnosis, and Treatment of Hepatocellular Carcinoma

Anjana Pillai, Sarah Park, A. Davis
article en
18 citations

Abstract

This JAMA Clinical Guidelines Synopsis summarizes the 2023 American Association for the Study of Liver Diseases practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma.

JAMAVol. 332(12)
University of Chicago (US)
Good health and well-being
Openalex Percentile: Top 2%
Hepatocellular Carcinoma Treatment and Prognosis
6.65
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Prevention, Diagnosis, and Treatment of Hepatocellular Carcinoma — Anjana Pillai, Sarah Park, et al. · JAMA (2024) | TGRS Research Map | TGRS